Taro Pharmaceutical Industries Ltd (NYSE:TARO)

101.50
Delayed Data
As of 4:01pm ET
 +0.38 / +0.38%
Today’s Change
93.01
Today|||52-Week Range
128.46
-3.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$4.0B

Company Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescription and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Taro's primary areas of focus include pediatric creams and ointments, liquids, capsules and tablets, mainly for the dermatological, topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay Haifa 26247
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Mutual fund holders7.30%
Other institutional5.90%
Individual stakeholders11.30%

Top Executives

Uday Vijaykumar BaldotaChief Executive Officer & Director
Itamar KarsentiVice President & Operations Head-Haifa
Mariano BalaguerVP, Chief Financial & Accounting Officer
Avi AvramoffGlobal Vice President-Research & Development
Stephen ManzanoSecretary, Group Vice President & General Counsel